Stay updated on Safety & Efficacy of SHP465 in Adults with ADHD Clinical Trial
Sign up to get notified when there's something new on the Safety & Efficacy of SHP465 in Adults with ADHD Clinical Trial page.

Latest updates to the Safety & Efficacy of SHP465 in Adults with ADHD Clinical Trial page
- Check7 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2 with no substantive changes to study details or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check21 days agoChange DetectedPublications section updated to clarify automatic PubMed population and potential irrelevance to the study, with revision changed to v3.3.1. The previous wording suggesting automatic creation tied to the NCT number (v3.2.0) was removed.SummaryDifference0.1%

- Check29 days agoChange DetectedRemoved the banner containing the government funding and NIH operating status notice from the page; this does not affect the study details or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check43 days agoChange DetectedNo significant additions or deletions were detected; the page content and details appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check71 days agoChange Detected- Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.SummaryDifference4%

- Check79 days agoChange DetectedIntroduced v3.1.0 and removed several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) along with v3.0.2 deletion notes. Overall, core content in drug-safety areas is reduced while a new version label appears.SummaryDifference0.4%

Stay in the know with updates to Safety & Efficacy of SHP465 in Adults with ADHD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Efficacy of SHP465 in Adults with ADHD Clinical Trial page.